Endoscopic Nasobiliary Drainage (ENBD) is a minimally invasive procedure used to drain bile from the biliary system to relieve jaundice or other complications caused by bile duct obstruction. A small catheter is placed through the nose into the bile duct to allow bile to flow externally or internally.
Endoscopic Nasobiliary Drainage (ENBD) is a minimally invasive procedure used to drain bile from the biliary system to relieve jaundice or other complications caused by bile duct obstruction. A small catheter is placed through the nose into the bile duct to allow bile to flow externally or internally.
Type 1 autoimmune pancreatitis (AIP) is a form of chronic pancreatitis often associated with IgG4-related disease. It is characterized by pancreatic inflammation, swelling, and narrowing of the bile duct, which can lead to obstructive jaundice. Differentiating AIP from malignancies and managing bile duct obstruction are crucial in treatment.
Biliary drainage in type 1 AIP is necessary to relieve jaundice and assess bile duct abnormalities. It helps in distinguishing AIP from malignancies and evaluating the patient’s response to steroid therapy while minimizing invasive procedures.
In a study of 83 patients with type 1 AIP and jaundice, ENBD effectively improved liver function and provided clear bile duct visualization. It was safe, with only 2% experiencing mild complications. ENBD also helped avoid repeated ERCP procedures and confirmed steroid responsiveness. This study highlights ENBD as a useful and safe option for managing jaundice in type 1 AIP, depending on the patient’s condition and pancreatic structure.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.